NCT03501576 2026-02-11
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Emory University
Recruiting
Clinical Trials
10 trialsNCT02518555 2026-01-07
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT01949129 2024-01-16
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung
Phase 2/3 Recruiting
NCT04484532 2023-06-06
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT04626765 2020-11-13
CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia
Hebei Senlang Biotechnology Inc., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04221971 2020-10-01
NK Cell Infusion for Patients With Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1 Unknown
NCT01135329 2018-07-03
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01215981 2017-12-28
Influenza Vaccine Post Allogeneic Transplant
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00596336 2017-04-12
CLLIFVAC
The Royal Bournemouth Hospital
Phase 2 Terminated
NCT00022035 2013-01-31
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
Roswell Park Cancer Institute
Phase NA Completed